Dublin, May 24, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Novel Autism Diagnostics" report to their offering. Autism spectrum disorder (ASD) includes many syndromes that can range in severity from the social awkwardness and narrow interests to severe communication and intellectual disabilities. There is a growing demand for cost efficient tests that can help physicians diagnose and monitor chronic diseases such autism. There is therefore a market opportunity for highly sensitive, specific and cost effective screening tests for early diagnosis. Novel Autism Diagnostics examines selected autism test innovations that have emerged. Novel Autism Diagnostics outlines many of the current approaches to autism testing, including molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. The competitors discussed within the company profiles include Asuragen, Google Genomics, Illumina, and LabCorp. The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. Key Topics Covered: ONE: EXECUTIVE SUMMARY Overview of ASD Leading Competitors Methodology
TWO: NOVEL AUTISM DIAGNOSTICS Overview of Autism Screening and Diagnosis Developmental Screening Comprehensive Diagnostic Evaluation Emerging Diagnostics Potential Market Research
THREE: COMPANY PROFILES Ambry Genetics Corp. ARUP Laboratories Asuragen Inc. Controls Sample Collection Sequencing Athena Diagnostics, Inc. (A Quest Diagnostics Business) Claritas Genomics, Inc. CombiMatrix Corp. Oncology Courtagen Life Sciences, Inc. Emory Genetics Laboratory GenePeeks, Inc. Genoma SA (a Subsidiary of the Esperite group) Google Genomics Greenwood Genetic Center Illumina Sequencing Sequencing Kits Sample Prep IVD Business Oncology HLA Typing IT Forensics CLIA Lab Service Nanopore Sequencing Sample to Insight Making a Market IP Situation IntegraGen LabCorp, Laboratory Corporation of America Infectious Diseases Prenatal Sequencing Oncology BRCA Saga Information Technology Forensic Collaborations Life Technologies Corporation Instrumentation and Applications Liquid Biopsy Sequencing Life Technologies an IVD Company Partnerships Worldwide Life and Quidel Develop Diagnostics on the 7500 Fast Dx Sepsis HIV Emerging Pathogens Bacterial Typing Personalized Medicine Forensic Lineagen, Inc. MEDomics, LLC Population Diagnostics RainDance Technologies, Inc. SynapDx Corporation Transgenomic, Inc. For more information visit http://www.researchandmarkets.com/research/hm...vel_autism
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Diagnostics, In Vitro Diagnostics